Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when NEO files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: NEO NEOGENOMICS INC 8-K

NeoGenomics General Counsel Alicia Olivo to depart September 21

Filed August 11, 2026 · Period ending August 7, 2026 · ~1 min read

2 key changes

Key Changes

  • medium

    Alicia Olivo, EVP, General Counsel & Business Development, will cease serving as General Counsel on September 21, 2026, and remain employed through October 2 for transition. No reason disclosed, no successor named.

  • low

    Olivo will receive separation payments and benefits per Section 5(b) of her employment agreement; specific amounts not disclosed in this filing.

Summary

NeoGenomics disclosed that Alicia Olivo, its Executive Vice President, General Counsel, and head of Business Development, will transition out of her role. She will cease serving as General Counsel on September 21, 2026, and remain employed through October 2 to assist with the transition. The filing does not disclose the reason for her departure or name a successor.

For retail holders, the departure of a senior legal and business development executive creates a leadership gap at a time when the company may need continuity in those functions. The absence of a named successor and the lack of explanation for the departure leave open questions about whether this is a planned transition or reflects underlying issues. Olivo will receive separation benefits under her existing employment agreement, though the specific amounts are not disclosed in this filing.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 12, 2026 · How we verify